Theoreo Srl is an innovative company, a spin off of the Department of Medicine and Surgery of the University of Salerno. The main scope of activity is represented by diagnostic techniques based on metabolomics and classification models and machine learning.
The company Theoreo Srl is developing innovative diagnostic tests for the early non invasive diagnosis of fetal malformations and endometrial carcinoma.
This technology has the potential to revolutionize prenatal and oncological care globally, saving lives and reducing overall health costs dramatically.

Theoreo is one of the partner of GEMMA project, an international study funded by the European Commission under the Horizon 2020 program.
GEMMA, an acronym for Genome, Environment, Microbiome and Metabolomics in Autism, is a multicenter project aimed at exploring the interactions between intestinal microbiome, metabolome, epigenome and immune function in order to discover new biomarkers useful for the early diagnosis of autism and as potential targets for preventive personalized therapies.


On July 17, 2015 was broadcast service on gluten sensitivity of note on Rai 1 Superquark griato in research laboratories of Theoreo

mama test Video Presentation

Video Presentation of the early and nono invasive siagnostic Test callede "MAMA Test" develop by Theoreo laboratories

Theoreo is certified ISO 9001:2015